Patents by Inventor Kun Se Lee

Kun Se Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL VERO CELL LINE THAT CAN BE SUSPENSION-CULTURED IN SERUM-FREE MEDIUM, PREPARATION METHOD THEREFOR, AND METHOD FOR PREPARING VIRUSES FOR VACCINES BY USING NOVEL CELL LINE
    Publication number: 20220411760
    Abstract: The present disclosure relates to sVERO 7C2, which is a Vero cell line derived from Vero cells (African Green Monkey Kidney Cell Line) distributed from the WHO and capable of suspension culture without serum components. Further, the present disclosure relates to a culture method for growing the Vero cells and a method for producing a vaccine virus using the Vero cells.
    Type: Application
    Filed: November 25, 2020
    Publication date: December 29, 2022
    Inventors: Jun-seok KWAK, Eun-som KIM, Hun KIM, Ki-weon SEO, Kun Se LEE, Sujeen LEE, Seung-hye HONG
  • MDCK-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells
    Patent number: 9447383
    Abstract: Disclosed is a Madin-Darby canine kidney (MDCK)-derived cell line. The MDCK-derived cell line is derived from MDCK cells deposited under accession number ATCC CCL-34. The MDCK-derived cell line can be prepared by serum-free culture and suspension culture. Preferably, the MDCK-derived cell line has low or no tumorigenicity. The MDCK-derived cell line is preferably selected from MDCK Sky1023, MDCK Sky10234 and MDCK Sky3851. Further disclosed are a culture method for growing the MDCK-derived cells and a method for producing a vaccine virus using the MDCK-derived cells.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: September 20, 2016
    Assignee: SK Chemicals Co., Ltd.
    Inventors: Yong Wook Park, Kun Se Lee, Bong-Yong Lee, Mahnhoon Park, Hun Kim, Yun-Hee Kim, Su-Jeen Lee
  • MDCK-DERIVED CELL LINES ADAPTED TO SERUM-FREE CULTURE AND SUSPENSION CULTURE AND METHOD FOR PREPARING VACCINE VIRUS USING THE CELLS
    Publication number: 20150247128
    Abstract: Disclosed is a Madin-Darby canine kidney (MDCK)-derived cell line. The MDCK-derived cell line is derived from MDCK cells deposited under accession number ATCC CCL-34. The MDCK-derived cell line can be prepared by serum-free culture and suspension culture. Preferably, the MDCK-derived cell line has low or no tumorigenicity. The MDCK-derived cell line is preferably selected from MDCK Sky1023, MDCK Sky10234 and MDCK Sky3851. Further disclosed are a culture method for growing the MDCK-derived cells and a method for producing a vaccine virus using the MDCK-derived cells.
    Type: Application
    Filed: May 13, 2015
    Publication date: September 3, 2015
    Inventors: Yong Wook Park, Kun Se Lee, Bong-Yong Lee, Mahnhoon Park, Hun Kim, Yun-Hee Kim, Su-Jeen Lee